BioKansas CEO Stepping Down After Nearly Four Years
Retrieved on:
Thursday, January 24, 2019
Health, Biotechnology, Hospitals, Medical devices, Pharmaceutical, Kansas City metropolitan area, UNESCO Creative Cities Network, Stowers Institute for Medical Research, Merck, Kansas City, Missouri, Stowers, Geography of Missouri, Metropolitan areas of the United States, Cities in the United States
BioKansas today announced that Dennis Ridenour, President & CEO, will be stepping down, effective February 8th.
Key Points:
- BioKansas today announced that Dennis Ridenour, President & CEO, will be stepping down, effective February 8th.
- Ridenour has accepted the President & CEO position at BioNexus KC, another Kansas City non-profit organization working within the life sciences.
- Ridenour joined BioKansas in May 2015, after spending nearly 13 years working as a scientific researcher at organizations such as Harvard Medical School, Merck Research Labs and the Stowers Institute for Medical Research.
- About BioKansas: BioKansas serves as the voice of the bioscience community in Kansas, connecting, educating and advocating to grow bioscience jobs in human, animal and plant science technologies across the state.